Although such evidence is mounting, it does not yet support the general treatment of asymptomatic hyperuricemia to reduce cardiovascular risk.

Objective: To develop an oral administration to reduce the uric acid in vivo for treatment of hyperuricemia and gout, non-growing E.

Conclusion high uric acid and high blood fat have very important influence on cerebral infarction, so we should actively carry out necessary treatment for reducing blood fat and uric acid.